Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • KLM Axiva Finvest to Raise Up to Rs 15,000 Lakhs via NCDs Business
  • Times Now Doctors Day Conclave: Experts call for ‘risk- grading’ of tobacco products in India Health
  • Dynamic Cables announced its result for Q4 and FY 23, Surpasses all Past Performances Business
  • Six Top DJs of the country perform at Vandal Bar lounge, Meluha The Fern Powai, Mumbai Entertainment
  • South actress Tanishq Rajan Tiwari will be seen in a lead role in a Hindi web horror show KALWA Releasing on 5th April Atrangii Entertainment
  • Shipwaves Online Ltd Announces INR 56.35 Cr SME IPO; To Open on December 10th 2025 Business
  • Allcommerce Recently Launched Supplybuy.in: Transforming Omni-Channel Sales and B2B Procurement for FMCG Players Business
  • VITS Hotels and Resorts expansion is all set to create thousands of jobs and contribute to the growth of the local economies in each destination from South to North India Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • My Health, My Right: Piece of Advice from Leading Health Experts on World Health Day 2024 Health
  • Himaya Multispeciality Hospital-A COVID-19 Isolation Center that grown into a modern 54 bed Hospital Health
  • Insights from Leading Health Experts on World Health Day 2024: My Health, My Right Health
  • Dr. Harshmeet Arora Was Given The Healthcare And Fitness Award Health
  • Endovascular Procedures Transforming Lives Health
  • LordsMed announces the launch of its first Pathology Centre in Maharashtra Health

Recent Posts

  • Hitesh Ahuja Says Cybersecurity Is No Longer Optional, It Is a Business Necessity in the AI Era
  • DHS Multispecialty Hospital inaugurates new twin tower, launches J&J VELYS Robotic Knee Replacement System in Ahmedabad
  • Hello Setu Media & Entertainment Unveils Poster of ‘Shri Ganesh Vandana’
  • Georgia Emerges as the Gateway to High-Yield Real Estate Investment for International Buyers
  • SBS University Records Notable Placement Outcomes with Strong Career Support

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • United Heat Transfer Limited IPO Opens on 22nd October 2024 Business
  • MotoGP Bharat City Tour reaches Ahmedabad; 500 plus bikers join to celebrate their passion for biking Lifestyle
  • EZOK Launches Exclusive Collection At Venus Steps, New Delhi Business
  • Marketing Veteran Rahul Goyal Launches Nuvoraa to Serve Brands Beyond Real Estate Business
  • Maximus International Limited Reports Strong Q2 & H1 FY2025-26 Results; Robust Growth in Profitability and Financial Strength Business
  • Qaid – No Wayyy Out’ Set for Release in India, Announces Sonia W. Kohli Entertainment
  • The Global Festival of Wellness Suhana Swasthyam second edition to be held in Pune from 1st to 3rd of Dec 2023 Business
  • IPO Sensation: Menhood’s Parent Company, Macobs Technologies Limited, Gears Up for Major NSE Emerge Debut Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme